- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Alkermes PLC+ Add to Watchlist
ALKS:US62.2600 USD 1.1900 1.88%
As of 20:10:00 ET on 04/24/2015.
Company Profile for Alkermes PLC (ALKS)
Alkermes PLC researches pharmaceuticals. The Company develops treatments for central nervous system disorders such as addiction, schizophrenia and depression, and diabetes.
Key Executives for Alkermes PLC (ALKS)
|Richard F PopsChairman/CEO||Shane M CookePresident|
|James M Frates "Jim"Senior VP/CFO/Treasurer||Gordon G PughSenior VP/COO/Chief Risk Ofcr|
|Mark StejbachSenior VP/Chief Commercial Ofcr||Kathryn L BibersteinSenior VP/Chief Legal Ofcr/Chief Compliance|
|Michael J Landine "Mike"Senior VP:Corporate Development||Elliot W EhrichSenior VP:R&D/Chief Medical Officer|
|Rebecca J PetersonSenior VP:Corp Communication|